Evidence map›Paper›PMID 42801620›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

GSLR Drives Lung Adenocarcinoma as a Critical Regulator of Energy Homeostasis Through Creatine Kinase B Activation.

Xinyi Qian, Juze Yang, Jiayi Ren, Xiaowei Mao, Jia Li, Tengfei Sun, Liangliang Dong, Enguo Chen, Yan Lu, Pengyuan Liu

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xinyi Qian *Department of Pulmonary and Critical Care Medicine, Regional Medical Center For National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.ORCID https://orcid.org/0000-0002-6108-3386
Juze Yang *Department of Pulmonary and Critical Care Medicine, Regional Medical Center For National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Jiayi Ren *Department of Pulmonary and Critical Care Medicine, Regional Medical Center For National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Xiaowei MaoDepartment of Pulmonary and Critical Care Medicine, Regional Medical Center For National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.ORCID https://orcid.org/0000-0003-2226-611X
Jia LiDepartment of Pulmonary and Critical Care Medicine, Regional Medical Center For National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Tengfei SunDepartment of Pulmonary and Critical Care Medicine, Regional Medical Center For National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Liangliang DongDepartment of Pulmonary and Critical Care Medicine, Regional Medical Center For National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Enguo ChenDepartment of Pulmonary and Critical Care Medicine, Regional Medical Center For National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.ORCID https://orcid.org/0000-0003-2338-8610
Yan LuZhejiang Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Department of Gynecologic Oncology, Women's Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.ORCID https://orcid.org/0000-0002-5004-4656
Pengyuan LiuDepartment of Pulmonary and Critical Care Medicine, Regional Medical Center For National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.ORCID https://orcid.org/0000-0002-8386-8416

Funding

China Postdoctoral Science Foundation 2023M733100National Natural Science Foundation of China 82203241National Natural Science Foundation of China 82302897National Natural Science Foundation of China 82472625Zhejiang Provincial Leading Geese Plan 2025C02053Zhejiang Provincial Natural Science Foundation of China LMS25H160009
6 · The paper itself

Abstract

Lung cancer remains the leading cause of cancer-related mortality, with extremely high energy demands during progression. Long non-coding RNAs (lncRNAs) have emerged as crucial regulators in cancer metabolism; however, their role in reprogramming energy metabolism in lung cancer remains incompletely understood. In this study, we identify a glucose/glutamine sensitive lncRNA, GSLR, as a driver of lung adenocarcinoma (LUAD) progression. GSLR is markedly upregulated in LUAD, and its high expression is associated with poor patient prognosis. Nutrient restriction reduces chromatin accessibility at the GSLR locus via altered histone marks, whereas CTCF activates its transcription. Mechanistically, GSLR directly binds the RNA helicase DHX9 and recruits it to the creatine kinase B (CKB) promoter, arresting R-loop accumulation and thereby promoting CKB transcription. Elevated CKB expression sustains intracellular ATP homeostasis, thereby stabilizing mitochondrial membrane potential, preventing calcium overload, and reducing reactive oxygen species (ROS) accumulation. Collectively, our findings identify GSLR as a novel regulator of energy homeostasis that promotes lung cancer progression through the GSLR/DHX9/CKB axis. Targeting GSLR may thus represent a promising therapeutic strategy for LUAD.

Indexed as

energy homeostasisepigenetic regulationlong non‐coding RNAlung adenocarcinoma

Identifiers

PMID42801620
PMCPMC13616385

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.